Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver

被引:98
|
作者
Washington, K
Wright, K
Shyr, Y
Hunter, EB
Olson, S
Raiford, DS
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
关键词
nonalcoholic steatohepatitis; fibrosis; steatosis; hepatic stellate cell;
D O I
10.1053/hupa.2000.8440
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Factors associated with the development of fibrosis in nonalcoholic steatohepatitis (NASH) are largely unknown, although an association with increased hepatic iron has been suggested. Hepatic stellate cells are the principal collagen-producing cells in many liver diseases and when activated express alpha-smooth muscle actin (alpha-SMA). Hepatic stellate cell activation and association with fibrosis, necroinflammatory activity steatosis, and stainable iron in 60 cases of NASH and 16 cases of steatosis were evaluated. All 76 patients were obese or had other risk factors for NASH. All biopsy specimens were stained for alpha-smooth muscle actin to evaluate the pattern of hepatic stellate cell activation and were evaluated for inflammatory activity (0 to 3), fibrosis (0 to 4), and stainable iron stores (0 to 4). The zonal location of activated stellate cells was recorded, and the degree of activation was graded as high-grade or low-grade based on the percentage of lobular alpha-SMA+ cells. Activated stellate cells were identified in the hepatic lobule in 74 of 76 biopsy specimens and graded as low-grade in 26 and high-grade in 48. Zone 3 was involved in 72 of 74 positive cases, and in 33 cases, the activated stellate cells were preferentially located in zone 3, The degree of stellate cell activation correlated with fibrosis but not with inflammatory activity, severity of steatosis, or stainable iron. In most cases, the degree of stellate cell activation paralleled the degree of hepatic fibrosis, but in 25 cases, the degree of hepatic stellate cell activation was greater than expected, raising the question of whether such patients are at risk for disease progression. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:822 / 828
页数:7
相关论文
共 50 条
  • [41] The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Kazankov, Konstantin
    Jorgensen, Simon Mark Dahl
    Thomsen, Karen Louise
    Moller, Holger Jon
    Vilstrup, Hendrik
    George, Jacob
    Schuppan, Detlef
    Gronbaek, Henning
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (03) : 145 - 159
  • [42] The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Konstantin Kazankov
    Simon Mark Dahl Jørgensen
    Karen Louise Thomsen
    Holger Jon Møller
    Hendrik Vilstrup
    Jacob George
    Detlef Schuppan
    Henning Grønbæk
    Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 145 - 159
  • [43] Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Esterson, Yonah B.
    Grimaldi, Gregory M.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 93 - +
  • [44] Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Golabi, Pegah
    Bush, Haley
    Younossi, Zobair M.
    CLINICS IN LIVER DISEASE, 2017, 21 (04) : 739 - 753
  • [45] Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Imajo, Kento
    Yoneda, Masato
    Kessoku, Takaomi
    Ogawa, Yuji
    Maeda, Shin
    Sumida, Yoshio
    Hyogo, Hideyuki
    Eguchi, Yuichiro
    Wada, Koichiro
    Nakajima, Atsushi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11) : 21833 - 21857
  • [46] Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Soejima, Yurie
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (19) : 2300 - 2308
  • [47] Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Gawrieh, Samer
    Chalasani, Naga
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 189 - +
  • [48] Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
    Sakamoto, Michiie
    Tsujikawa, Hanako
    Effendi, Kathryn
    Ojima, Hidenori
    Harada, Kenichi
    Zen, Yoh
    Kondo, Fukuo
    Nakano, Masayuki
    Kage, Masayoshi
    Sumida, Yoshio
    Hashimoto, Etsuko
    Yamada, Gotaro
    Okanoue, Takeshi
    Koike, Kazuhiko
    PATHOLOGY INTERNATIONAL, 2017, 67 (01) : 1 - 7
  • [49] Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Kogachi, Shannon
    Noureddin, Mazen
    CLINICAL THERAPEUTICS, 2021, 43 (03) : 455 - 472
  • [50] Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Younossi, Zobair
    Tacke, Frank
    Arrese, Marco
    Sharma, Barjesh Chander
    Mostafa, Ibrahim
    Bugianesi, Elisabetta
    Wong, Vincent Wai-Sun
    Yilmaz, Yusuf
    George, Jacob
    Fan, Jiangao
    Vos, Miriam B.
    HEPATOLOGY, 2019, 69 (06) : 2672 - 2682